Atossa Therapeutics Granted Additional Patent Protection for Endoxifen
SEATTLE, Aug. 28, 2024 ( GLOBE NEWSWIRE ) -- Atossa Therapeutics, Inc. ( Nasdaq: ATOS ) ( "Atossa" or the "Company" ) , today announced that the United States Patent and Trademark Office ( USPTO ) has granted a new patent ( U.S. Patent No. 12,071,391 ) directed to compositions comprising ...
| Ticker |
Sentiment |
Impact |
|
AEXAF
|
Neutral
|
4 %
|
|
ATOS
|
Neutral
|
13 %
|
